Wikipedia
Naurex
Naurex Inc. is a pharmaceutical company which is developing the drug candidates rapastinel ( GLYX-13) and apimostinel (NRX-1074), NMDA receptor modulators, as novel, next-generation antidepressants.
On July 26, 2015, it was announced that Allergan would be acquiring Naurex for $560 million.